All G Brings Precision-Fermented Apo-Lactoferrin to US Market at Multi-Tonne Scale

Australian biotechnology company All G has introduced LFX, a precision-fermented bovine lactoferrin with under 5% iron saturation, to the US market on a multi-tonne scale. This apo-lactoferrin is the first of its kind to be available to manufacturers at commercial quantities and is positioned for use in dietary supplements, functional foods, and beverages targeting gut health, immune support, women’s health, and healthy aging.

The low iron saturation of LFX, matching that found in human breast milk, is a key selling point for the ingredient. All G is currently producing LFX at a 60,000-litre scale in China through a contract manufacturer, with plans for a second production facility in Europe. The company's innovative approach to lactoferrin production has garnered interest from companies seeking a scientifically differentiated ingredient for their formulations.